Insider Transactions in Q4 2020 at Biocryst Pharmaceuticals Inc (BCRX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2020
|
Jon P Stonehouse President & CEO |
SELL
Open market or private sale
|
Direct |
134,278
-14.62%
|
$1,074,224
$8.32 P/Share
|
|
Dec 15
2020
|
Jon P Stonehouse President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
134,278
+12.76%
|
$537,112
$4.15 P/Share
|
|
Dec 11
2020
|
Alane P Barnes Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
13,741
-11.28%
|
$96,187
$7.96 P/Share
|
|
Dec 11
2020
|
Alane P Barnes Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,741
+10.14%
|
$54,964
$4.15 P/Share
|
|
Dec 04
2020
|
Alane P Barnes Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
13,741
-11.28%
|
$82,446
$6.23 P/Share
|
|
Dec 04
2020
|
Alane P Barnes Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,741
+10.14%
|
$54,964
$4.15 P/Share
|
|
Nov 30
2020
|
Robert Alexander Ingram Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,669
+4.77%
|
$18,345
$5.11 P/Share
|
|
Nov 30
2020
|
Nancy J Hutson Director |
BUY
Grant, award, or other acquisition
|
Direct |
978
+1.5%
|
$4,890
$5.11 P/Share
|
|
Nov 30
2020
|
Steve Aselage Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,956
+6.01%
|
$9,780
$5.11 P/Share
|
|
Nov 30
2020
|
Theresa Heggie Director |
BUY
Grant, award, or other acquisition
|
Direct |
978
+6.81%
|
$4,890
$5.11 P/Share
|